These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12586310)

  • 1. The telomere hypothesis for progressive liver cirrhosis.
    Murphy F; Iredale J
    J Hepatol; 2003 Mar; 38(3):378-9. PubMed ID: 12586310
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
    Wiemann SU; Satyanarayana A; Tsahuridu M; Tillmann HL; Zender L; Klempnauer J; Flemming P; Franco S; Blasco MA; Manns MP; Rudolph KL
    FASEB J; 2002 Jul; 16(9):935-42. PubMed ID: 12087054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis.
    Laish I; Mannasse-Green B; Hadary R; Biron-Shental T; Konikoff FM; Amiel A; Kitay-Cohen Y
    Cytogenet Genome Res; 2016; 150(2):93-99. PubMed ID: 28006764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
    Lechel A; Manns MP; Rudolph KL
    J Hepatol; 2004 Sep; 41(3):491-7. PubMed ID: 15336455
    [No Abstract]   [Full Text] [Related]  

  • 5. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD.
    Nakajima T; Moriguchi M; Katagishi T; Sekoguchi S; Nishikawa T; Takashima H; Kimura H; Minami M; Itoh Y; Kagawa K; Tani Y; Okanoue T
    Liver Int; 2006 Feb; 26(1):23-31. PubMed ID: 16420506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Telomere Maintenance and Liver Disease.
    Barnard A; Moch A; Saab S
    Gut Liver; 2019 Jan; 13(1):11-15. PubMed ID: 30400735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere shortening in chronic liver diseases.
    Kitada T; Seki S; Kawakita N; Kuroki T; Monna T
    Biochem Biophys Res Commun; 1995 Jun; 211(1):33-9. PubMed ID: 7779103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere shortening as genetic risk factor of liver cirrhosis.
    Carulli L
    World J Gastroenterol; 2015 Jan; 21(2):379-83. PubMed ID: 25593453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis.
    Laish I; Mannasse-Green B; Hadary R; Konikoff FM; Amiel A; Kitay-Cohen Y
    Gene; 2016 Nov; 593(1):162-166. PubMed ID: 27520584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
    Invernizzi P; Bernuzzi F; Lleo A; Pozzoli V; Bignotto M; Zermiani P; Crosignani A; Battezzati PM; Zuin M; Podda M; Raggi C
    Dig Liver Dis; 2014 Apr; 46(4):363-8. PubMed ID: 24378524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
    Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
    Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhosis and constitutional telomerase mutations.
    Hiriart JB; Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):607-9. PubMed ID: 21978439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
    Donaires FS; Scatena NF; Alves-Paiva RM; Podlevsky JD; Logeswaran D; Santana BA; Teixeira AC; Chen JJ; Calado RT; Martinelli ALC
    PLoS One; 2017; 12(8):e0183287. PubMed ID: 28813500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase gene mutations are associated with cirrhosis formation.
    Hartmann D; Srivastava U; Thaler M; Kleinhans KN; N'kontchou G; Scheffold A; Bauer K; Kratzer RF; Kloos N; Katz SF; Song Z; Begus-Nahrmann Y; Kleger A; von Figura G; Strnad P; Lechel A; Günes C; Potthoff A; Deterding K; Wedemeyer H; Ju Z; Song G; Xiao F; Gillen S; Schrezenmeier H; Mertens T; Ziol M; Friess H; Jarek M; Manns MP; Beaugrand M; Rudolph KL
    Hepatology; 2011 May; 53(5):1608-17. PubMed ID: 21520174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium and liver cirrhosis: a hypothesis.
    Cohen L
    Magnesium; 1985; 4(1):1-4. PubMed ID: 4033201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
    Oh BK; Jo Chae K; Park C; Kim K; Jung Lee W; Han KH; Nyun Park Y
    J Hepatol; 2003 Nov; 39(5):786-92. PubMed ID: 14568262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomere involvement.
    Carulli L; Dei Cas A; Nascimbeni F
    Hepatology; 2012 Nov; 56(5):2001-3. PubMed ID: 23045155
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in gene therapy of liver cirrhosis: a review.
    Dai WJ; Jiang HC
    World J Gastroenterol; 2001 Feb; 7(1):1-8. PubMed ID: 11819724
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of direct-acting antivirals on leukocytic DNA telomere length in hepatitis C virus-related hepatic cirrhosis.
    Demerdash HM; Elyamany AS; Arida E
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):494-498. PubMed ID: 30444746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models.
    Sanches SC; Ramalho LN; Augusto MJ; da Silva DM; Ramalho FS
    Biomed Res Int; 2015; 2015():574832. PubMed ID: 26064924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.